Sponsored Content
Advertisement
Articles by Sponsored Content
Vincent Herrin, MD - University of Mississippi Medical Center Jackson, Mississippi
Advertisement
Latest Updated Articles
- The Proposed Mechanism of Action of POLIVY for R/R DLBCL, NOS
February 1st 2020
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Community Clinical Trials and the Lung Cancer Pipeline
2
MCED Testing: Preparing for the Next Era of Cancer Risk Assessment
3
Biomarkers Beyond High TMB or MMR-D May Be Needed for ICIs in Sarcomas
4
First Patient Is Dosed in Trial of HLX-4310 for Relapsed/Refractory Osteosarcoma
5